Labcorp, Opko

Labcorp to buy Opko unit’s cancer test assets for up to $225M
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth testing areas.
Labcorp to acquire select oncology testing assets for up to $225M
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp to acquire certain assets of Opko Health’s BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets
Opko Health to sell more assets to Labcorp for $225 million
The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for unnecessary blood tests.
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for BioReference's laboratory testing businesses, which is focused on oncology and oncology-related clinical testing services across the U.S.
Labcorp to Acquire Select Assets of BioReference Health
Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
Labcorp to acquire select assets of BioReference Health's innovative oncology and related clinical testing services businesses
Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST]
Labcorp Acquiring BioReference Health Oncology Testing Assets for $225M
The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health,
Labcorp pays $225 million for BioReference's oncology testing lines in latest acquisition
Labcorp continues string of acquisitions with a deal adding BioReference oncology services in $225 million deal. Burlington-based Labcorp is investing almost a quarter of a billion dollars to add oncology testing services in its most recent acquisition.
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing assets from BioReference Health (OPK) for $192.5M, with an ...
Hosted on MSN11mon
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Laboratory Corporation Of America Holdings (NYSE:LH) acquires certain operations of Opko Health, Inc‘s (NASDAQ:OPK) subsidiary BioReference Health. The assets Labcorp is acquiring generate about ...
Labcorp, Opko Health acquire certain assets of BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...